We are live on
!
Find out more
BAM
Broadcrest Asset Management Portfolio holdings
AUM
$44.1M
1-Year Est. Return
4.51%
This Fund
S&P 500
This Quarter
Est. Return
-11.15%
1 Year Est. Return
-4.51%
3 Year Est. Return
+54.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.8M
AUM Growth
-$16.4M
(-20%)
Cap. Flow
-$7.34M
Cap. Flow
% of AUM
-11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$7.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 80.94% |
| 2 | Healthcare | 10.79% |
| 3 | Consumer Discretionary | 8.28% |
Similar funds
MAM
WCPI
NLVP
WAMC
CIEP
IPI
CC
VSAM
Broadcrest Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Broadcrest Asset Management held 4 positions worth $66.8M, down 20% from $83.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadcrest Asset Management withdrew a net $7.34M in Q4 2024, reducing 1 holding. Its largest reduction was Bio-Techne, cutting an estimated $7.34M.
By sector, the portfolio is most concentrated in Industrials at 81% of assets, up from 73% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Broadcrest Asset Management's biggest Q4 2024 reduction was Bio-Techne, cutting an estimated $7.34M.
- Broadcrest Asset Management's ten largest holdings make up 100% of its $66.8M portfolio in Q4 2024.
- Broadcrest Asset Management opened 0 new positions and closed 0 in Q4 2024.
- Broadcrest Asset Management's portfolio value fell 20% quarter-over-quarter to $66.8M.
Based on Broadcrest Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.